StockData
CASI Pharmaceuticals, Inc. logo

CASI Pharmaceuticals, Inc. (CASIF) stock

CASIFOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 1/30
$0.10+0.00 (0.00%)

Close on Oct 19, 2026Market cap –P/E –Yield –

CASI Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2025 it was $20.71M, down 27.4% from the year before. The highest annual figure on record is $43.11M in fiscal 2022.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.71M-27.4%
FY2024Dec 31, 2024$28.54M-15.8%
FY2023Dec 31, 2023$33.88M-21.4%
FY2022Dec 31, 2022$43.11M+42.9%
FY2021Dec 31, 2021$30.17M+99.2%
FY2020Dec 31, 2020$15.14M–

More CASI Pharmaceuticals figures

See a number that looks wrong?